Verified Clinical Trials (VCT) will be exhibiting again at the EUFEMED meeting in France May 15-17. VCT is the global research subject database registry utilized by phase 1- phase 4 clinical trials across the globe. VCT prevents over enrollment or duplicate subjects as well as many other key protocol violations to promote safety and data
The Verified Clinical Trials Research Subject Registry Reduces Duplicate Subjects And Professional Research Subjects In CNS Clinical Trials
The Verified Clinical Trials Research Subject Registry Reduces Duplicate Subjects And Professional Research Subjects In CNS Clinical Trials. Verified Clinical Trials is a global research subject database registry. The registry is used by thousands of research sites across the US and in Europe to prevent many protocol deviations and most importantly, duplicate subjects in clinical
Characteristics Of Professional Research Subjects and Duplicate Subjects In CNS and Other Clinical Trials Prevented By Verified Clinical Trials
Professional research subjects or duplicate subjects in clinical trials cause safety concerns and poor quality data. The Verified Clinical Trials global research subject database registry is a tool to detect duplicate subjects and prevents many protocol violations proactively at the time of screening. What we have learned from experience and analytical data review over the
Research Sites Cooperate To Prevent Duplicate Subjects in CNS Clinical Trials By Using The Verified Clinical Trials Research Subject Registry
Duplicate subjects exist in most clinical trials to varying degrees. CNS clinical trials are especially prone to duplicate subject or over enrollment. The issue exists from phase 1 healthy volunteer studies to multiple phase 2/3 clinical trials across many therapeutic indications. Use of global research subject database registry such as Verified Clinical Trials will help
Professional Research Subjects Travel: Prevent Duplicate Subjects In Your Clinical Trials With Verified Clinical Trials
Mature data collected from North America as well as in Europe demonstrates how research volunteers will travel large distances to screen or enroll contemporaneously in multiple clinical trials as duplicate subjects in clinical trials. The numbers are significant and occur across both early and later phase studies. Why risk these safety and data quality issues?
Preventing Duplicate Subjects In European Clinical Trials: Average Travel Distance
Verified Clinical Trials (VCT) has been well adopted in many research sites and CROs in several European countries. Data again proves that research volunteers will travel significant distances to dual enroll in multiple clinical trials contemporaneously. There is a similar experience in the United States whereby duplicate subjects in clinical trials will travel thousands of
